A Senate hearing on high insulin costs billed as a blockbuster showdown with drugmakers and middlemen turned out to be a familiar case of political theater
Tag - Congress
WASHINGTON — President Biden’s presumed pick to lead the National Institutes of Health, Monica Bertagnolli, will face a slew of questions on the multibillion
WASHINGTON — The chair and ranking Republican on the Senate Finance Committee on Thursday unveiled a bipartisan list of overarching reforms to drug middlemen’s
WASHINGTON — Prescription drug middlemen are shifting away from rebates that have been blamed in part for rising brand drug list prices and are using new
WASHINGTON — President Biden made lowering drug prices a key part of his budget with proposals to expand Medicare drug price negotiation, squeeze more rebates
WASHINGTON — After nearly forty years of obscurity, the “food is medicine” movement is having a moment. Multiple federal agencies are working on food is
WASHINGTON — The Senate Judiciary Committee on Thursday passed legislation to prevent drug companies from gaming the patent system to delay competition from
A bipartisan group of senators fiercely criticized several prominent telehealth startups for failing to protect sensitive health information, citing an
The Senate finally made long-expected committee assignments official on Thursday, kickstarting a new session for the top health committee under an unlikely
In her latest bid to address prescription drug prices, U.S. Sen. Elizabeth Warren (D-Mass.) is urging the U.S. Federal Trade Commission to “closely scrutinize”
